Medical importance and pharmacokinetics of gold nanoparticles in the human body
Artikel i vetenskaplig tidskrift, 2025

Gold nanoparticles (AuNPs) have emerged as versatile nanocarriers with promising potential in therapeutic applications due to their tunable physicochemical properties, ease of functionalization, and excellent biocompatibility. Recognized as one of the most extensively studied nanomaterials, AuNPs have demonstrated utility in cancer diagnostics, photothermal therapy, targeted drug delivery, biosensing, vaccine development, antimicrobial treatments, gene delivery, imaging-guided therapy, and skin care formulations. While much research has focused on their design, formulations, and medical applications, understanding their fate within the human body is equally crucial. The long-term fate of AuNPs within the human body remains not well understood, largely due to the widely accepted notion that their inert nature impedes biodegradation. This review discusses the synthesis and biomedical applications of AuNPs, with a primary focus on recent advances in understanding their pharmacokinetic behavior in the human body guided by growing insights into their biological interactions, biodistribution, clearance mechanisms, and the key factors influencing there in vivo dynamics.

Clinical trials

Medical applications

Gold nanoparticles

Biodistribution

Toxicity

Pharmacokinetics

Författare

Priyanka Singh

Novo Nordisk Fonden

Abhayraj S. Joshi

Manipal University

Hina Singh

UCR School of Medicine

Ivan Mijakovic

Chalmers, Life sciences, Systembiologi

Novo Nordisk Fonden

Molecular Cancer

14764598 (eISSN)

Vol. 24 1 252

Ämneskategorier (SSIF 2025)

Annan kemi

Biomaterialvetenskap

DOI

10.1186/s12943-025-02418-3

PubMed

41068777

Mer information

Senast uppdaterat

2025-10-24